CRT 2026

Panel Discussion

Moderator(s)

• 

  Mariell Jessup, MD

  Chief Science and Medical Officer
  American Heart Association
  Philadelphia, Pennsylvania, United States

  Disclosure(s): No financial relationships to disclose
• 

  Bram Zuckerman, MD

  Director Office of CV Devices
  U.S. Food and Drug Administration
  Silver Spring, Maryland, United States

  Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

• 

  Daniel Burkhoff, MD, PhD

  Director: Heart Failure, Hemodynamics and MCS Research
  Cardiovascular Research Foundation
  New York, New York, United States

  Disclosure(s): Abiomed / Johnson & Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); OrchestraBiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)
• 

  Rafael Cavalcante, MD, PhD

  Vice President, Global Clinical
  Boston Scientific
  Newton, Massachusetts, United States

  Disclosure(s): Boston Scientific: Employee (Ongoing)
• 

  Andrew Farb, MD

  Chief Medical Officer, Office of Cardiovascular Devices
  U.S. Food and Drug Administration
  Silver Spring, Maryland, United States

  Disclosure information not submitted.
• 

  Navin K. Kapur, MD, FSCAI, FAHA, FACC

  Professor of Medicine
  Tufts Medical Center
  Boston, Massachusetts, United States

  Disclosure(s): Abiomed / Johnson & Johnson: Employee (Ongoing)
• 

  Mitchell Krucoff, MD, FACC, FAHA, FSCAI

  Professor Medicine/Cardiology
  Duke University Medical Center/Duke Clinical Research Institute
  Durham, North Carolina, United States

  Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abiomed / Johnson & Johnson: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Getinge: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Nipro Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Shockwave/Johnson&Johnson: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Terumo Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
• 

  Srihari S. Naidu, MD, MSCAI

  Director, Cath Labs and HCM Program
  Westchester Medical Center
  Valhalla, New York, United States

  Disclosure(s): No financial relationships to disclose
• GN

  Gerardo Noriega

  Disclosure information not submitted.
• SN

  Susan Noriega

  Disclosure information not submitted.
• CR

  Christine Rutan

  Disclosure information not submitted.